 |
 Video: What is a Stock Split?
|
|
|
| Eyenovia is a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs as well as out-licensing for additional indications. Co.'s drug-device therapeutic programs include MicroPine, MicroLine and Mydcombi™. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s investigational pharmacologic treatment for presbyopia. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis. According to our Eyenovia stock split history records, Eyenovia has had 0 splits. | |
|
Eyenovia (EYEN) has 0 splits in our Eyenovia stock split history database.
Looking at the Eyenovia stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Eyenovia shares, starting with a $10,000 purchase of EYEN, presented on a split-history-adjusted basis factoring in the complete Eyenovia stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/26/2018 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$9.95 |
|
| End price/share: |
$0.58 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.13% |
|
| Average Annual Total Return: |
-36.50% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$586.88 |
|
| Years: |
6.24 |
|
|
|
|
|
